| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Ophthalmology and
Neuroscience*
and Molecular Biology and
Genetics,
The Johns Hopkins University School
of Medicine, Baltimore, Maryland; and the Departments of Ophthalmology
and Cell Biology and Anatomy,
Weill Medical
College of Cornell University, New York, New York
Fibroblast growth factor-2 (FGF2) has neurotrophic effects in vitro and in vivo. It has been demonstrated to decrease photoreceptor cell death in rats exposed to constant light and in rats with an inherited defect in retinal pigmented epithelium (RPE) phagocytosis, but the effects of intravitreous injections of FGF2 in mice are equivocal. In this study, we used transgenic mice with increased expression of FGF2 in photoreceptors (rhodopsin promoter/FGF2 transgenics) to investigate the effects of sustained increased expression of FGF2 in mice with various types of photoreceptor degeneration, including rd mice that are homozygous for mutated phosphodiesterase ß subunit, Q344ter mice that undergo photoreceptor degeneration because of expression of mutated rhodopsin, and mice exposed to 75% oxygen for 1 or 2 weeks. At P21, the outer nuclear layer was markedly reduced in rd mice or Q344ter mice regardless of whether they inherited the rhodopsin promoter/FGF2 transgene. However, after 2 weeks of exposure to 75% oxygen, outer nuclear layer thickness was significantly reduced in littermate control mice compared to FGF2 transgenic mice (P = 0.0001). These data indicate that increased expression of FGF2 in photoreceptors protects them from hyperoxia-induced damage, but does not decrease cell death related to expression of mutated proteins involved in the phototransduction pathway. This suggests that FGF2 protects photoreceptors from oxidative damage, which may play a role in complex genetic diseases such as age-related macular degeneration.
This article has been cited by other articles:
 |
|
 |
|
  R. Natoli, J. Provis, K. Valter, and J. Stone Expression and Role of the Early-Response Gene Oxr1 in the Hyperoxia-Challenged Mouse Retina Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4561 - 4567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nachman-Clewner, F. J. Giblin, C. K. Dorey, R. H. I. Blanks, L. Dang, C. J. Dougherty, and J. C. Blanks Selective Degeneration of Central Photoreceptors after Hyperbaric Oxygen in Normal and Metallothionein-Knockout Mice Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3207 - 3215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Chrysostomou, J. Stone, S. Stowe, N. L. Barnett, and K. Valter The Status of Cones in the Rhodopsin Mutant P23H-3 Retina: Light-Regulated Damage and Repair in Parallel with Rods Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1116 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Smit-McBride, S. L. Oltjen, M. M. LaVail, and L. M. Hjelmeland A Strong Genetic Determinant of Hyperoxia-Related Retinal Degeneration on Mouse Chromosome 6 Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 405 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Komeima, B. S. Rogers, L. Lu, and P. A. Campochiaro Antioxidants reduce cone cell death in a model of retinitis pigmentosa PNAS, July 25, 2006; 103(30): 11300 - 11305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Hauck, N. Kinkl, C. A. Deeg, M. Swiatek-de Lange, S. Schoffmann, and M. Ueffing GDNF Family Ligands Trigger Indirect Neuroprotective Signaling in Retinal Glial Cells. Mol. Cell. Biol., April 1, 2006; 26(7): 2746 - 2757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Daniele, C. Lillo, A. L. Lyubarsky, S. S. Nikonov, N. Philp, A. J. Mears, A. Swaroop, D. S. Williams, and E. N. Pugh Jr Cone-like Morphological, Molecular, and Electrophysiological Features of the Photoreceptors of the Nrl Knockout Mouse Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2156 - 2167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Valter, S. Bisti, C. Gargini, S. Di Loreto, R. Maccarone, L. Cervetto, and J. Stone Time Course of Neurotrophic Factor Upregulation and Retinal Protection against Light-Induced Damage after Optic Nerve Section Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1748 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Paskowitz, G. Nune, D. Yasumura, H. Yang, R. B. Bhisitkul, S. Sharma, M. T. Matthes, M. A. Zarbin, M. M. LaVail, and J. L. Duncan BDNF Reduces the Retinal Toxicity of Verteporfin Photodynamic Therapy Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4190 - 4196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Hackam, R. Strom, D. Liu, J. Qian, C. Wang, D. Otteson, T. Gunatilaka, R. H. Farkas, I. Chowers, M. Kageyama, et al. Identification of Gene Expression Changes Associated with the Progression of Retinal Degeneration in the rd1 Mouse Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2929 - 2942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-Y. Yu, S. Cringle, K. Valter, N. Walsh, D. Lee, and J. Stone Photoreceptor Death, Trophic Factor Expression, Retinal Oxygen Status, and Photoreceptor Function in the P23H Rat Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 2013 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Ranchon, M. M. LaVail, Y. Kotake, and R. E. Anderson Free Radical Trap Phenyl-N-tert-Butylnitrone Protects against Light Damage But Does Not Rescue P23H and S334ter Rhodopsin Transgenic Rats from Inherited Retinal Degeneration J. Neurosci., July 9, 2003; 23(14): 6050 - 6057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Okoye, J. Zimmer, J. Sung, P. Gehlbach, T. Deering, H. Nambu, S. Hackett, M. Melia, N. Esumi, D. J. Zack, et al. Increased Expression of Brain-Derived Neurotrophic Factor Preserves Retinal Function and Slows Cell Death from Rhodopsin Mutation or Oxidative Damage J. Neurosci., May 15, 2003; 23(10): 4164 - 4172. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
